SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Hoglund Carina) "

Search: WFRF:(Hoglund Carina)

  • Result 1-2 of 2
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Hagell, Peter, et al. (author)
  • Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's disease
  • 2020
  • In: Journal of Neurology. - 0340-5354 .- 1432-1459. ; 267:11, s. 3411-3417
  • Journal article (peer-reviewed)abstract
    • Continuous subcutaneous (s.c.) apomorphine infusion is an effective therapy for Parkinson's disease (PD), but a limitation is the formation of troublesome s.c. nodules. Various chemically non-identical apomorphine formulations are available. Anecdotal experiences have suggested that shifting from one of these (Apo-Go PumpFill®; apoGPF) to another (Apomorphine PharmSwed®; apoPS) may influence the occurrence and severity of s.c. nodules. We, therefore, followed 15 people with advanced PD (median PD-duration, 15 years; median "off"-phase Hoehn and Yahr, IV) on apoGPF and with troublesome s.c. nodules who were switched to apoPS. Data were collected at baseline, at the time of switching, and at a median of 1, 2.5, and 7.3 months post-switch. Total nodule numbers (P < 0.001), size (P < 0.001), consistency (P < 0.001), skin changes (P = 0.058), and pain (P ≤ 0.032) improved over the observation period. PD severity and dyskinesias tended to improve and increase, respectively. Apomorphine doses were stable, but levodopa doses increased by 100 mg/day. Patient-reported apomorphine efficacy tended to increase and all participants remained on apoPS throughout the observation period; with the main patient-reported reason being improved nodules. These observations suggest that patients with s.c. nodules caused by apoGPF may benefit from switching to apoPS in terms of s.c. nodule occurrence and severity. Alternatively, observed benefits may have been due to the switch itself. As nodule formation is a limiting factor in apomorphine treatment, a controlled prospective study comparing local tolerance with different formulations is warranted.
  •  
2.
  • Croci, Gabriele, et al. (author)
  • I-BAND-GEM : a new way for improving BAND-GEM efficiency to thermal and cold neutrons
  • 2019
  • In: The European Physical Journal Plus. - : Springer Science and Business Media LLC. - 2190-5444. ; 134:4
  • Journal article (peer-reviewed)abstract
    • .The BAND-GEM detector represents one of the novel thermal neutron detection devices that have been developed in order to fulfil the needs of high intensity neutron sources that, like ESS (the European Spallation Source), will start operation in the next few years. The first version of this detector featured a detection efficiency of about 40% for neutrons with a wavelength of 4 angstrom, a spatial resolution of about 6mm and a rate capability in the order of some MHz/cm(2). The novelty of this device is represented by an improved 3D converter cathode (10 cm thick) based on (B4C)-B-10-coated aluminum grids positioned in a controlled gas mixture volume put on top of a Triple GEM amplifying stage. The position where the neutron interacts in the converter depends on their energy and it was observed that the first version of the detector would suffer from an efficiency decrease for long (>5 angstrom) neutron wavelength. This paper describes how the new 3D cathode allowed improving the detection efficiency at long neutron wavelengths while keeping all the benefits of the first BAND-GEM version.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-2 of 2

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view